Microbot Medical Inc.
NASDAQ:MBOTMedical - Instruments & Supplies
-$0.06 today
- Market cap
- $65.73M
- Beta
- 1.04
- P/E (TTM)
- -8.6
- EPS (TTM)
- -$0.21
Volume 0.87M
Average 1.60M
MBOT Weighted Avg Shares (Diluted)
Average shares outstanding including dilutive securities, used to calculate diluted EPS.
Microbot Medical Inc.NASDAQ: MBOT
Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026
Weighted avg shares (diluted) growth accelerates
Q1 FY2026 weighted avg shares (diluted) of 67.16M shares rose 294.6% year over year, ahead of the +234.9% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 0.0% from the prior quarter. Over 3 fiscal years it compounded at +84.8% a year.
Context
- Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +294.6% holds above the trailing-twelve-month pace of +234.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Weighted Avg Shares (Diluted) history
Shares · from the income statement
- Latest · FY2025
- 45.79M USD
- Year-over-year change
- +192.7%
- 4-year CAGR
- +59.3%
| Period | Period end | Weighted Avg Shares (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 45.79M | +192.7% |
| FY2024 | 2024-12-31 | 15.65M | +53.4% |
| FY2023 | 2023-12-31 | 10.2M | +40.5% |
| FY2022 | 2022-12-31 | 7.26M | +2.1% |
| FY2021 | 2021-12-31 | 7.11M | — |
Weighted Avg Shares (Diluted) vs competitors
How MBOT compares with its peers on the latest reported figures
- MBOT's LTM Mar 2026 weighted avg shares (diluted) of 54.72M shares is the 7th highest of the 10 companies compared; the peer median is 74.41M shares.
- Its year-over-year change of +234.9% is the highest of 10, against a peer median of +8.1%.
- Over three fiscal years its annual growth of +84.8% compares with a peer median of +3.7%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | 109.67M | +8.1% | +2.1% | |
| LTM Mar 2026 | 102.83M | -1.2% | -1.3% | |
| LTM Mar 2026 | 94.36M | +30.6% | +81.3% | |
| LTM Mar 2026 | 94.16M | +29.4% | +11.6% | |
| LTM Mar 2026 | 74.41M | +4.7% | +1.5% | |
| LTM Mar 2026 | 65.65M | +15.7% | +17.7% | |
| LTM Mar 2026 | 54.72M | +234.9% | +84.8% | |
| LTM Mar 2026 | 42.44M | +3.8% | +2.8% | |
| LTM Mar 2026 | 21.36M | -17.9% | +3.7% | |
| LTM Mar 2026 | 10.33M | +43.6% | +44.6% | |
| Peer median (excluding MBOT) | 74.41M | +8.1% | +3.7% | |
Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 106K | 91K | 0 |
| Gross Profit | 0 | 0 | (106K) | (91K) | 0 |
| Gross Margin | — | — | — | — | — |
| Research & Development | 6.15M | 7.74M | 5.72M | 6.63M | 6.28M |
| Selling, General & Admin | 5.41M | 5.58M | 4.13M | 5M | 8.25M |
| Operating Expenses | 11.36M | 13.28M | 9.75M | 11.53M | 14.74M |
| Depreciation & Amortization | 76K | 102K | 106K | 91K | 47K |
| EBITDA | (11.24M) | (13.34M) | (10.63M) | (11.35M) | (13.1M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (11.36M) | (13.28M) | (9.86M) | (11.63M) | (14.74M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 44K | 54K | 228K | 182K | 1.29M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 44K | 113K | (885K) | 182K | 1.6M |
| Income Before Tax | (11.31M) | (13.17M) | (10.74M) | (11.44M) | (13.14M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (11.31M) | (13.17M) | (10.74M) | (11.44M) | (13.14M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (1.59) | (1.81) | (1.05) | (0.73) | (0.29) |
| EPS (Diluted) | (1.59) | (1.81) | (1.05) | (0.73) | (0.29) |
| Weighted Avg Shares | 7.11M | 7.26M | 10.2M | 15.65M | 45.79M |
| Weighted Avg Shares (Diluted) | 7.11M | 7.26M | 10.2M | 15.65M | 45.79M |
Microbot Medical Inc.
NASDAQ:MBOT
Intrinsic Alpha fair value
Locked
Current Price
$0.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.